Adoptive transfer of ex vivo-activated m
β
Jay E. Gold; David T. Zachary; Michael E. Osband
π
Article
π
1995
π
John Wiley and Sons
π
French
β 850 KB
Autolymphocyte therapy (ALT) is adoptive cellular therapy of neoplastic disease using ex vivo activation of autologous (human) or syngeneic (murine) lymphocytes from tumor-bearing hosts (TBH) by low doses of anti-CD3 monoclonal antibody (MAb) and a mixture of previously prepared autologous cytokines